{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:21Z","timestamp":1792783101574,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anusandhan National Research Foundation (ANRF), Govt. of India","award":["MTR\/2022\/000286"],"award-info":[{"award-number":["MTR\/2022\/000286"]}],"id":[{"id":"https:\/\/ror.org\/00d4e4338","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11591-6","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:37:02Z","timestamp":1779543422000},"page":"8377-8394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An integrated machine learning and chemical space network approach for the design of potent epigenetic HDAC6 inhibitors for targeting neurological disorders"],"prefix":"10.1007","volume":"30","author":[{"given":"Indrasis","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupchand","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijeta","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insaf Ahmed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-7322","authenticated-orcid":false,"given":"Sk. Abdul","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-578X","authenticated-orcid":false,"given":"Shovanlal","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"24","key":"11591_CR1","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/cells14241997","volume":"14","author":"M Hawash","year":"2025","unstructured":"Hawash M, Next-Generation HDAC, Inhibitors (2025) Advancing zinc-binding group design for enhanced cancer therapy. Cells 14(24):1997","journal-title":"Cells"},{"issue":"5","key":"11591_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/ph17050620","volume":"17","author":"A Curcio","year":"2024","unstructured":"Curcio A, Rocca R, Alcaro S, Artese A (2024) The histone deacetylase family: structural features and application of combined computational methods. Pharmaceuticals 17(5):620","journal-title":"Pharmaceuticals"},{"issue":"12","key":"11591_CR3","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.drudis.2025.104544","volume":"30","author":"SA Ganai","year":"2025","unstructured":"Ganai SA, Bhat M, Padder SA (2025) Choosing pan-HDAC or selective HDAC inhibitors for anticancer therapy. Drug Discovery Today 30(12):104544. https:\/\/doi.org\/10.1016\/j.drudis.2025.104544","journal-title":"Drug Discovery Today"},{"key":"11591_CR4","doi-asserted-by":"publisher","first-page":"105274","DOI":"10.1016\/j.phrs.2020.105274","volume":"163","author":"S Pulya","year":"2021","unstructured":"Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B (2021) HDAC6 as privileged target in drug discovery: a perspective. Pharmacol Res 163:105274. https:\/\/doi.org\/10.1016\/j.phrs.2020.105274","journal-title":"Pharmacol Res"},{"issue":"9","key":"11591_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nchembio.2134","volume":"12","author":"Y Hai","year":"2016","unstructured":"Hai Y, Christianson DW (2016) Histone deacetylase 6 structure and molecular basis of catalysis and inhibition. Nat Chem Biol 12(9):741\u2013747. https:\/\/doi.org\/10.1038\/nchembio.2134","journal-title":"Nat Chem Biol"},{"key":"11591_CR6","doi-asserted-by":"publisher","first-page":"116057","DOI":"10.1016\/j.ejmech.2023.116057","volume":"265","author":"S Jha","year":"2024","unstructured":"Jha S, Kim JH, Kim M, Nguyen A-H, Ali KH, Gupta SK et al (2024) Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue. Eur J Med Chem 265:116057. https:\/\/doi.org\/10.1016\/j.ejmech.2023.116057","journal-title":"Eur J Med Chem"},{"issue":"49","key":"11591_CR7","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1021\/acs.biochem.9b00934","volume":"58","author":"JD Osko","year":"2019","unstructured":"Osko JD, Christianson DW (2019) Structural basis of catalysis and inhibition of HDAC6 CD1, the enigmatic catalytic domain of histone deacetylase 6. Biochemistry 58(49):4912\u20134924. https:\/\/doi.org\/10.1021\/acs.biochem.9b00934","journal-title":"Biochemistry"},{"issue":"26","key":"11591_CR8","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1021\/acs.biochem.8b00367","volume":"57","author":"NJ Porter","year":"2018","unstructured":"Porter NJ, Wagner FF, Christianson DW (2018) Entropy as a driver of selectivity for inhibitor binding to histone deacetylase 6. Biochemistry 57(26):3916\u20133924. https:\/\/doi.org\/10.1021\/acs.biochem.8b00367","journal-title":"Biochemistry"},{"key":"11591_CR9","doi-asserted-by":"publisher","first-page":"123219","DOI":"10.1016\/j.ijbiomac.2023.123219","volume":"230","author":"Y-C Zheng","year":"2023","unstructured":"Zheng Y-C, Kang H-Q, Wang B, Zhu Y-Z, Mamun MAA, Zhao L-F et al (2023) Curriculum vitae of HDAC6 in solid tumors. Int J Biol Macromol 230:123219. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123219","journal-title":"Int J Biol Macromol"},{"key":"11591_CR10","doi-asserted-by":"publisher","first-page":"105278","DOI":"10.1016\/j.bioorg.2021.105278","volume":"116","author":"S Li","year":"2021","unstructured":"Li S, Zhao C, Zhang G, Xu Q, Liu Q, Zhao W et al (2021) Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity. Bioorg Chem 116:105278. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105278","journal-title":"Bioorg Chem"},{"issue":"5","key":"11591_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s13402-022-00704-6","volume":"45","author":"S Kaur","year":"2022","unstructured":"Kaur S, Rajoria P, Chopra M (2022) HDAC6: A unique HDAC family member as a cancer target. Cell Oncol 45(5):779\u2013829. https:\/\/doi.org\/10.1007\/s13402-022-00704-6","journal-title":"Cell Oncol"},{"issue":"1","key":"11591_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/pharmaceutics16010054","volume":"16","author":"A Vuleti\u0107","year":"2024","unstructured":"Vuleti\u0107 A, Mirja\u010di\u0107 Martinovi\u0107 K, Spasi\u0107 J (2024) Role of histone deacetylase 6 and histone deacetylase 6 inhibition in colorectal cancer. Pharmaceutics 16(1):54","journal-title":"Pharmaceutics"},{"key":"11591_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1383663","author":"D Lin","year":"2024","unstructured":"Lin D, Lai W, Zheng N, Luo H, Chen X, Que W et al (2024) Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1383663","journal-title":"Front Pharmacol"},{"issue":"9","key":"11591_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.4049\/immunohorizons.2400028","volume":"8","author":"D Xu","year":"2024","unstructured":"Xu D, Luo XM, Reilly CM (2024) HDAC6 deletion decreases pristane-induced inflammation. ImmunoHorizons 8(9):668\u2013678. https:\/\/doi.org\/10.4049\/immunohorizons.2400028","journal-title":"ImmunoHorizons"},{"issue":"1","key":"11591_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1021\/acs.jmedchem.9b00924","volume":"63","author":"M Brindisi","year":"2020","unstructured":"Brindisi M, Saraswati AP, Brogi S, Gemma S, Butini S, Campiani G (2020) Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases. J Med Chem 63(1):23\u201339. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00924","journal-title":"J Med Chem"},{"issue":"2","key":"11591_CR16","doi-asserted-by":"publisher","first-page":"151202","DOI":"10.1016\/j.ejcb.2022.151202","volume":"101","author":"AA Balmik","year":"2022","unstructured":"Balmik AA, Chinnathambi S (2022) Inter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling. Eur J Cell Biol 101(2):151202. https:\/\/doi.org\/10.1016\/j.ejcb.2022.151202","journal-title":"Eur J Cell Biol"},{"issue":"7","key":"11591_CR17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1021\/acsmedchemlett.5c00344","volume":"16","author":"SH Liang","year":"2025","unstructured":"Liang SH (2025) Novel heterocyclic 5H-Dibenzo[b,f]azepine derivatives as selective HDAC6 Inhibitors for treatment of charcot marie tooth disease. ACS Med Chem Lett 16(7):1245\u20131246. https:\/\/doi.org\/10.1021\/acsmedchemlett.5c00344","journal-title":"ACS Med Chem Lett"},{"issue":"20","key":"11591_CR18","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1021\/acschemneuro.5c00723","volume":"16","author":"A Mazumder","year":"2025","unstructured":"Mazumder A, Mondal P, Zhang C (2025) HDAC6 as a modulator of DNA repair in Alzheimer\u2019s disease: from mechanisms to therapeutic perspectives. ACS Chem Neurosci 16(20):3915\u20133918. https:\/\/doi.org\/10.1021\/acschemneuro.5c00723","journal-title":"ACS Chem Neurosci"},{"key":"11591_CR19","doi-asserted-by":"publisher","first-page":"130318","DOI":"10.1016\/j.bmcl.2025.130318","volume":"127","author":"B Dang","year":"2025","unstructured":"Dang B, Chen H, Liu S, Liu H, Kang Z, Yang Z et al (2025) Histone deacetylase 6 inhibitors in Alzheimer\u2019s disease therapy: structure design and challenges. Bioorg Med Chem Lett 127:130318. https:\/\/doi.org\/10.1016\/j.bmcl.2025.130318","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"11591_CR20","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","volume":"106","author":"H Ding","year":"2008","unstructured":"Ding H, Dolan PJ, Johnson GVW (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106(5):2119\u20132130. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05564.x","journal-title":"J Neurochem"},{"key":"11591_CR21","doi-asserted-by":"publisher","first-page":"113874","DOI":"10.1016\/j.ejmech.2021.113874","volume":"226","author":"Y Li","year":"2021","unstructured":"Li Y, Sang S, Ren W, Pei Y, Bian Y, Chen Y et al (2021) Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer\u2019s disease: a review (2010\u20132020). Eur J Med Chem 226:113874. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113874","journal-title":"Eur J Med Chem"},{"issue":"1","key":"11591_CR22","doi-asserted-by":"publisher","first-page":"15423","DOI":"10.1038\/s41598-021-94923-w","volume":"11","author":"T Onishi","year":"2021","unstructured":"Onishi T, Maeda R, Terada M, Sato S, Fujii T, Ito M et al (2021) A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer\u2019s disease and tauopathy in mice. Sci Rep 11(1):15423. https:\/\/doi.org\/10.1038\/s41598-021-94923-w","journal-title":"Sci Rep"},{"issue":"1","key":"11591_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/emmm.201201923","volume":"5","author":"N Govindarajan","year":"2013","unstructured":"Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schl\u00fcter OM, Bradke F et al (2013) Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease. EMBO Mol Med 5(1):52\u201363. https:\/\/doi.org\/10.1002\/emmm.201201923","journal-title":"EMBO Mol Med"},{"issue":"2","key":"11591_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/jad-2012-120727","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang L, Sheng S, Qin C (2013) The role of HDAC6 in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease 33(2):283\u2013295. https:\/\/doi.org\/10.3233\/jad-2012-120727","journal-title":"J Alzheimer\u2019s Disease"},{"key":"11591_CR25","doi-asserted-by":"publisher","first-page":"103457","DOI":"10.1016\/j.redox.2024.103457","volume":"79","author":"K-Y Pham","year":"2025","unstructured":"Pham K-Y, Khanal S, Bohara G, Rimal N, Song S-H, Nguyen TTK et al (2025) HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson\u2019s disease. Redox Biol 79:103457. https:\/\/doi.org\/10.1016\/j.redox.2024.103457","journal-title":"Redox Biol"},{"issue":"1","key":"11591_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12967-025-06602-3","volume":"23","author":"K Wang","year":"2025","unstructured":"Wang K, Zhu L, Ren Z (2025) CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson\u2019s disease: a novel neuroprotective axis. J Translational Med 23(1):570. https:\/\/doi.org\/10.1186\/s12967-025-06602-3","journal-title":"J Translational Med"},{"key":"11591_CR27","doi-asserted-by":"publisher","first-page":"105141","DOI":"10.1016\/j.neuint.2021.105141","volume":"149","author":"Y Du","year":"2021","unstructured":"Du Y, Yang X, Li Z, Le W, Hao Y, Song Y et al (2021) HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy. Neurochem Int 149:105141. https:\/\/doi.org\/10.1016\/j.neuint.2021.105141","journal-title":"Neurochem Int"},{"issue":"10","key":"11591_CR28","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.neurobiolaging.2014.04.029","volume":"35","author":"Y Du","year":"2014","unstructured":"Du Y, Wang F, Zou J, Le W, Dong Q, Wang Z et al (2014) Histone deacetylase 6 regulates cytotoxic \u03b1-synuclein accumulation through induction of the heat shock response. Neurobiol Aging 35(10):2316\u20132328. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.04.029","journal-title":"Neurobiol Aging"},{"issue":"9","key":"11591_CR29","doi-asserted-by":"publisher","first-page":"e00361","DOI":"10.1002\/brb3.361","volume":"5","author":"A Ragot","year":"2015","unstructured":"Ragot A, Pietropaolo S, Vincent J, Delage P, Zhang H, Allinquant B et al (2015) Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6\/1 mouse model for Huntington\u2019s disease. Brain Behav 5(9):e00361. https:\/\/doi.org\/10.1002\/brb3.361","journal-title":"Brain Behav"},{"issue":"48","key":"11591_CR30","doi-asserted-by":"publisher","first-page":"40282","DOI":"10.1074\/jbc.M508786200","volume":"280","author":"A Iwata","year":"2005","unstructured":"Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin *. J Biol Chem 280(48):40282\u201340292. https:\/\/doi.org\/10.1074\/jbc.M508786200","journal-title":"J Biol Chem"},{"issue":"2","key":"11591_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5483\/BMBRep.2022-0157","volume":"56","author":"E Li","year":"2023","unstructured":"Li E, Choi J, Sim HR, Kim J, Jun JH, Kyung J et al (2023) A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington\u2019s disease. BMB Rep 56(2):178\u2013183. https:\/\/doi.org\/10.5483\/BMBRep.2022-0157","journal-title":"BMB Rep"},{"key":"11591_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00068","author":"X Xu","year":"2014","unstructured":"Xu X, Kozikowski A, Pozzo-Miller L (2014) A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2014.00068","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"11591_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00109-014-1202-x","volume":"93","author":"WA Gold","year":"2015","unstructured":"Gold WA, Lacina TA, Cantrill LC, Christodoulou J (2015) MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors. J Mol Med 93(1):63\u201372. https:\/\/doi.org\/10.1007\/s00109-014-1202-x","journal-title":"J Mol Med"},{"issue":"9","key":"11591_CR34","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/acscentsci.7b00274","volume":"3","author":"MG Strebl","year":"2017","unstructured":"Strebl MG, Campbell AJ, Zhao W-N, Schroeder FA, Riley MM, Chindavong PS et al (2017) HDAC6 brain mapping with [18F]bavarostat enabled by a ru-mediated deoxyfluorination. ACS Cent Sci 3(9):1006\u20131014. https:\/\/doi.org\/10.1021\/acscentsci.7b00274","journal-title":"ACS Cent Sci"},{"issue":"3","key":"11591_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/brain\/awx375","volume":"141","author":"V Benoy","year":"2018","unstructured":"Benoy V, Van Helleputte L, Prior R, d\u2019Ydewalle C, Haeck W, Geens N et al (2018) HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. Brain 141(3):673\u2013687. https:\/\/doi.org\/10.1093\/brain\/awx375","journal-title":"Brain"},{"issue":"8","key":"11591_CR36","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1021\/acs.jmedchem.0c02210","volume":"64","author":"S Shen","year":"2021","unstructured":"Shen S, Picci C, Ustinova K, Benoy V, Kutil Z, Zhang G et al (2021) Tetrahydroquinoline-capped histone deacetylase 6 inhibitor SW-101 ameliorates pathological phenotypes in a Charcot\u2013Marie\u2013Tooth Type 2A mouse model. J Med Chem 64(8):4810\u20134840. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02210","journal-title":"J Med Chem"},{"issue":"2","key":"11591_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jns.12623","volume":"29","author":"ALD Tadenev","year":"2024","unstructured":"Tadenev ALD, Hatton CL, Burgess RW (2024) Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D. J Peripheral Nerv Syst 29(2):213\u2013220. https:\/\/doi.org\/10.1111\/jns.12623","journal-title":"J Peripheral Nerv Syst"},{"issue":"22","key":"11591_CR38","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1021\/acschemneuro.5c00649","volume":"16","author":"A Bansal","year":"2025","unstructured":"Bansal A, Sharma AR, Chakraborty A, Sunkaria A, Jain A (2025) Machine learning\u2013based bioactivity prediction and descriptor-guided rational design of Amyloid-\u03b2 aggregation inhibitors. ACS Chem Neurosci 16(22):4351\u20134363. https:\/\/doi.org\/10.1021\/acschemneuro.5c00649","journal-title":"ACS Chem Neurosci"},{"key":"11591_CR39","doi-asserted-by":"publisher","first-page":"108051","DOI":"10.1016\/j.compbiolchem.2024.108051","volume":"110","author":"S Banerjee","year":"2024","unstructured":"Banerjee S, Jana S, Jha T, Ghosh B, Adhikari N (2024) An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches. Comput Biol Chem 110:108051. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108051","journal-title":"Comput Biol Chem"},{"key":"11591_CR40","doi-asserted-by":"publisher","unstructured":"Tinkov OV, Grigorev VY, Grigoreva LD, Osipov VN, Kolotaev AV, Khachatryan DS (2023) HDAC6 detector: online application for evaluating compounds as potential histone deacetylase 6 inhibitors. SAR and QSAR in Environmental Research. 34(8):619\u2013637. https:\/\/doi.org\/10.1080\/1062936X.2023.2244419","DOI":"10.1080\/1062936X.2023.2244419"},{"key":"11591_CR41","doi-asserted-by":"publisher","unstructured":"Tinkov OV, Grigorev VY, Grigoreva LD, Osipov VN, Kolotaev AV, Khachatryan DS (2022) QSAR analysis and experimental evaluation of new quinazoline-containing hydroxamic acids as histone deacetylase 6 inhibitors. SAR QSAR Environm Res. 33(7):513\u2013532. https:\/\/doi.org\/10.1080\/1062936X.2022.2092210","DOI":"10.1080\/1062936X.2022.2092210"},{"issue":"3","key":"11591_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11030-022-10474-w","volume":"27","author":"L Zhao","year":"2023","unstructured":"Zhao L, Fu L, Li G, Yu Y, Wang J, Liang H et al (2023) Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors. Mol Diversity 27(3):1123\u20131140. https:\/\/doi.org\/10.1007\/s11030-022-10474-w","journal-title":"Mol Diversity"},{"issue":"6","key":"11591_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/1062936X.2024.2371155","volume":"35","author":"OV Tinkov","year":"2024","unstructured":"Tinkov OV, Osipov VN, Kolotaev AV, Khachatryan DS, Grigorev VY (2024) HT_PREDICT: a machine learning-based computational open-source tool for screening HDAC6 inhibitors. SAR QSAR Environ Res 35(6):505\u2013530. https:\/\/doi.org\/10.1080\/1062936X.2024.2371155","journal-title":"SAR QSAR Environ Res"},{"issue":"D1","key":"11591_CR44","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100\u2013D7","journal-title":"Nucleic Acids Res"},{"key":"11591_CR45","doi-asserted-by":"crossref","unstructured":"Pilgrim M (2009) Serializing python objects. In: Dive Into Python 3. Berkeley, CA: Apress, pp 205-223.","DOI":"10.1007\/978-1-4302-2416-7_13"},{"key":"11591_CR46","unstructured":"Van Rossum G (2007) Python programming language. USENIX annual technical conference: Santa Clara, CA; pp 1\u201336"},{"key":"11591_CR47","volume-title":"Network analysis with python","author":"A Hagberg","year":"2020","unstructured":"Hagberg A, Conway D, Networkx (2020) Network analysis with python. https:\/\/networkx github io."},{"key":"11591_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-00456-1","volume":"12","author":"AP Bento","year":"2020","unstructured":"Bento AP, Hersey A, F\u00e9lix E, Landrum G, Gaulton A, Atkinson F et al (2020) An open source chemical structure curation pipeline using RDKit. J Cheminform 12:1\u201316","journal-title":"J Cheminform"},{"issue":"4","key":"11591_CR49","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1007\/s11030-025-11217-3","volume":"29","author":"RP Bhagat","year":"2025","unstructured":"Bhagat RP, Jyotisha, Dasgupta I, Amin SA, Jakkula P, Bhattacharya A et al (2025) First report on analysis of chemical space, scaffold diversity, critical structural features of HDAC11 inhibitors. Mol Div 29(4):3679\u20133702. https:\/\/doi.org\/10.1007\/s11030-025-11217-3","journal-title":"Mol Diversity"},{"issue":"15","key":"11591_CR50","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39(15):2887\u20132893","journal-title":"J Med Chem"},{"issue":"6","key":"11591_CR51","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1021\/jm500022q","volume":"57","author":"NM O\u2019Boyle","year":"2014","unstructured":"O\u2019Boyle NM, Bostr\u00f6m J, Sayle RA, Gill A (2014) Using matched molecular series as a predictive tool to optimize biological activity. J Med Chem 57(6):2704\u20132713. https:\/\/doi.org\/10.1021\/jm500022q","journal-title":"J Med Chem"},{"issue":"3","key":"11591_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/1062936X.2026.2649822","volume":"37","author":"I Dasgupta","year":"2026","unstructured":"Dasgupta I, Roy R, Gayen S (2026) Optima: a GUI-based toolkit for developing and validating interpretable machine learning based supervised classification QSAR models. SAR QSAR Environ Res 37(3):241\u2013257. https:\/\/doi.org\/10.1080\/1062936X.2026.2649822","journal-title":"SAR QSAR Environ Res"},{"issue":"10","key":"11591_CR53","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/ci300338w","volume":"52","author":"TM Martin","year":"2012","unstructured":"Martin TM, Harten P, Young DM, Muratov EN, Golbraikh A, Zhu H et al (2012) Does rational selection of training and test sets improve the outcome of QSAR modeling? J Chem Inf Model 52(10):2570\u20132578. https:\/\/doi.org\/10.1021\/ci300338w","journal-title":"J Chem Inf Model"},{"issue":"38","key":"11591_CR54","doi-asserted-by":"publisher","first-page":"10378","DOI":"10.1039\/D0SC03115A","volume":"11","author":"T Le","year":"2020","unstructured":"Le T, Winter R, No\u00e9 F, Clevert D-A (2020) Neuraldecipher\u2013reverse-engineering extended-connectivity fingerprints (ECFPs) to their molecular structures. Chem Sci 11(38):10378\u201310389","journal-title":"Chem Sci"},{"key":"11591_CR55","doi-asserted-by":"publisher","first-page":"138119","DOI":"10.1016\/j.ijbiomac.2024.138119","volume":"284","author":"S Khatun","year":"2025","unstructured":"Khatun S, Dasgupta I, Sen S, Amin SA, Qureshi IA, Jha T et al (2025) Histone deacetylase 8 in focus: decoding structural prerequisites for innovative epigenetic intervention beyond hydroxamates. Int J Biol Macromol 284:138119. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138119","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"11591_CR56","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","volume":"25","author":"I Sushko","year":"2011","unstructured":"Sushko I, Novotarskyi S, K\u00f6rner R, Pandey AK, Rupp M, Teetz W et al (2011) Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information. J Comput Aided Mol Des 25(6):533\u2013554. https:\/\/doi.org\/10.1007\/s10822-011-9440-2","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"11591_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki H, Tian Y-S, Kawashita N, Takagi T (2018) Mordred: a molecular descriptor calculator. J Cheminform 10(1):4. https:\/\/doi.org\/10.1186\/s13321-018-0258-y","journal-title":"J Cheminform"},{"key":"11591_CR58","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/978-1-0716-0150-1_32","volume-title":"Ecotoxicological QSARs","author":"A Mauri","year":"2020","unstructured":"Mauri A, alvaDesc (2020) A tool to calculate and analyze molecular descriptors and fingerprints. In: Roy K (ed) Ecotoxicological QSARs. Springer US, New York, NY, pp 801\u2013820"},{"key":"11591_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemolab.2015.07.007","volume":"147","author":"P Ambure","year":"2015","unstructured":"Ambure P, Aher RB, Gajewicz A, Puzyn T, Roy K (2015) NanoBRIDGES software: open access tools to perform QSAR and nano-QSAR modeling. Chemometr Intell Lab Syst 147:1\u201313. https:\/\/doi.org\/10.1016\/j.chemolab.2015.07.007","journal-title":"Chemometr Intell Lab Syst"},{"issue":"9","key":"11591_CR60","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.chemrestox.3c00155","volume":"36","author":"A Banerjee","year":"2023","unstructured":"Banerjee A, Roy K (2023) Prediction-inspired intelligent training for the development of classification read-across structure\u2013activity relationship (c-RASAR) models for organic skin sensitizers: assessment of classification error rate from novel similarity coefficients. Chem Res Toxicol 36(9):1518\u20131531. https:\/\/doi.org\/10.1021\/acs.chemrestox.3c00155","journal-title":"Chem Res Toxicol"},{"key":"11591_CR61","doi-asserted-by":"crossref","unstructured":"Akiba T, Sano S, Yanase T, Ohta T, Koyama M, Optuna (2019) A next-generation hyperparameter optimization framework. In: Proceedings of the 25th ACM SIGKDD international conference on knowledge discovery & data mining. Anchorage, AK, USA: Association for Computing Machinery; pp 2623\u201331","DOI":"10.1145\/3292500.3330701"},{"issue":"null","key":"11591_CR62","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O et al (2011) Scikit-learn: machine learning in Python. J Mach Learn Res 12(null):2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"11","key":"11591_CR63","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S (2024) Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development. Clin Transl Sci 17(11):e70056. https:\/\/doi.org\/10.1111\/cts.70056","journal-title":"Clin Transl Sci"},{"issue":"7","key":"11591_CR64","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"11591_CR65","unstructured":"Wickham BM (2020) [Hadley Wickham] R Packages Organize, Test, Document, and Share Your Code"},{"issue":"1","key":"11591_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13321-022-00664-x","volume":"14","author":"VF Scalfani","year":"2022","unstructured":"Scalfani VF, Patel VD, Fernandez AM (2022) Visualizing chemical space networks with RDKit and NetworkX. J Cheminform 14(1):87. https:\/\/doi.org\/10.1186\/s13321-022-00664-x","journal-title":"J Cheminform"},{"issue":"6","key":"11591_CR67","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1021\/ml400470s","volume":"5","author":"F Chen","year":"2014","unstructured":"Chen F, Chai H, Su M-B, Zhang Y-M, Li J, Xie X et al (2014) Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors. ACS Med Chem Lett 5(6):628\u2013633. https:\/\/doi.org\/10.1021\/ml400470s","journal-title":"ACS Med Chem Lett"},{"key":"11591_CR68","doi-asserted-by":"publisher","first-page":"143787","DOI":"10.1016\/j.molstruc.2025.143787","volume":"1349","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, Zhang M, Liang Z, Liu X, Kong W, Hu L et al (2026) Discovery of novel benzyl indole histone deacetylase inhibitors for efficient treatment of colorectal cancer. J Mol Struct 1349:143787. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143787","journal-title":"J Mol Struct"},{"issue":"15","key":"11591_CR69","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1021\/jm980565u","volume":"42","author":"T Suzuki","year":"1999","unstructured":"Suzuki T, Ando T, Tsuchiya K, Fukazawa N, Saito A, Mariko Y et al (1999) Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J Med Chem 42(15):3001\u20133003. https:\/\/doi.org\/10.1021\/jm980565u","journal-title":"J Med Chem"},{"issue":"5","key":"11591_CR70","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/cbdd.13019","volume":"90","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Dun Y, Fu H, Wang L, Pan X, Yang X et al (2017) Design, synthesis, and preliminary bioactivity evaluation of N-benzylpyrimidin-2-amine derivatives as novel histone deacetylase inhibitor. Chem Biol Drug Des 90(5):936\u2013942. https:\/\/doi.org\/10.1111\/cbdd.13019","journal-title":"Chem Biol Drug Des"},{"issue":"15","key":"11591_CR71","doi-asserted-by":"publisher","first-page":"15738","DOI":"10.1021\/acs.jmedchem.5c00717","volume":"68","author":"A Citarella","year":"2025","unstructured":"Citarella A, Belluti S, Bonanni D, Moi D, Piccinini I, Rinaldi A et al (2025) Structure-based discovery of Hsp90\/HDAC6 dual inhibitors targeting aggressive prostate cancer. J Med Chem 68(15):15738\u201315765. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00717","journal-title":"J Med Chem"},{"key":"11591_CR72","doi-asserted-by":"publisher","first-page":"109772","DOI":"10.1016\/j.bioorg.2026.109772","volume":"175","author":"S Shawky","year":"2026","unstructured":"Shawky S, Ahmed TE, Haffez H, Sobhy A, Soror S, Jaballah M et al (2026) Towards the discovery of potent epigenetic modulators: design, synthesis, biological evaluation, and SAR investigation of novel indole-based derivatives targeting HDAC1 and HDAC6. Bioorg Chem 175:109772. https:\/\/doi.org\/10.1016\/j.bioorg.2026.109772","journal-title":"Bioorg Chem"},{"issue":"1","key":"11591_CR73","doi-asserted-by":"publisher","first-page":"2627711","DOI":"10.1080\/14756366.2026.2627711","volume":"41","author":"C Ye","year":"2026","unstructured":"Ye C, Chen Z, Jiang J, Li J, Kong R, Liu S et al (2026) Design, synthesis and antiproliferative activity of oxadiazole derivatives as potent glycogen synthase kinase-3\/histone deacetylase 6 dual inhibitors. J Enzyme Inhib Med Chem 41(1):2627711. https:\/\/doi.org\/10.1080\/14756366.2026.2627711","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11591_CR74","doi-asserted-by":"publisher","first-page":"115730","DOI":"10.1016\/j.ejmech.2023.115730","volume":"260","author":"D Moi","year":"2023","unstructured":"Moi D, Bonanni D, Belluti S, Linciano P, Citarella A, Franchini S et al (2023) Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer. Eur J Med Chem 260:115730. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115730","journal-title":"Eur J Med Chem"},{"key":"11591_CR75","doi-asserted-by":"publisher","first-page":"105380","DOI":"10.1016\/j.chemolab.2025.105380","volume":"261","author":"C Rojas","year":"2025","unstructured":"Rojas C, Abril-Gonz\u00e1lez M, Ballabio D, Garc\u00eda F, ChemTastesPredictor (2025) An ensemble of machine learning classifiers to predict the taste of molecular tastants. Chemometr Intell Lab Syst 261:105380. https:\/\/doi.org\/10.1016\/j.chemolab.2025.105380","journal-title":"Chemometr Intell Lab Syst"},{"issue":"1","key":"11591_CR76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13321-025-01122-0","volume":"17","author":"H Teimouri","year":"2025","unstructured":"Teimouri H, Haghighijoo Z, Baumgartner TJ, Singh AK, Wadsworth PA, Zhang C et al (2025) Uncovering molecular determinants of potency and binding affinity in hit compounds targeting FGF14\/Nav1.6 complex. J Cheminform 17(1):176. https:\/\/doi.org\/10.1186\/s13321-025-01122-0","journal-title":"J Cheminform"},{"issue":"8","key":"11591_CR77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/1062936X.2025.2552134","volume":"36","author":"I Dasgupta","year":"2025","unstructured":"Dasgupta I, Gayen S (2025) First report on machine learning based multiclass classification of Caco-2 permeability using different balancing strategies. SAR QSAR Environ Res 36(8):701\u2013725. https:\/\/doi.org\/10.1080\/1062936X.2025.2552134","journal-title":"SAR QSAR Environ Res"},{"key":"11591_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111670","author":"AK Halder","year":"2021","unstructured":"Halder AK, Cordeiro MNDS (2021) Multi-target in silico prediction of inhibitors for mitogen-activated protein kinase-interacting kinases. Biomolecules. https:\/\/doi.org\/10.3390\/biom11111670","journal-title":"Biomolecules"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11591-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:40Z","timestamp":1791121660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11591-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":78,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11591"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11591-6","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}